TrialJournal of cancer research and clinical oncology2015

Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study.

Andreas Hochhaus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.